English (United Kingdom)

https://curated-unify.zendy.io/wp-json/zendy-region/v1/featured_content/oa?rat=en

https://curated-unify.zendy.io/wp-json/zendy-region/v1/highlighted_journal/

Global: Zendy Plus annual

Presents the access of premium content as premium feature

Premium Content

Presents the keyphrase highlighting as premium feature

Keyphrase Highlighting

Presents the summarisation as premium feature

Summarisation

Insights

Presents the pdf analysis as premium feature

PDF Analysis

Presents the zaia usage as premium feature

ZAIA

Global: Zendy Tools annual

Global: Zendy Free Plan

Global: Zendy Tools monthly

Global: Zendy Plus monthly

Background. epidemiological reports show a systematic growth of incidences of ovarian cancer. The treatment for this type of cancer is associated with substantial physical and psychological burden on the patients. Objectives. The aim of the current study was to compare the quality of life of patients treated for ovarian cancer and to evaluate the impact of selected quantitative variables. Material and methods. a questionnaire study was carried out among 101 patients of the oncological Gynaecology ward of maria Sklodowska-Curie oncology Centre in białystok. The control group was 100 healthy women undergoing routine periodic health examinations. in order to evaluate the women’s quality of life, we used the european organisation for research and Treatment of Cancer (eorTC) questionnaires: Quality of life Questionnaire Core 30 QlQ-C30, module for ovarian cancer QlQ-oV28 and an original questionnaire concerning the respondents’ sociodemographic data. Results. The evaluation of the respondents’ overall quality of life showed that the quality of life of women with ovarian cancer is much lower than that of healthy women. only in the area of gastrointestinal complaints and cognitive functions were there no statistically significant differences, and the p-factor was as follows: cognitive functions – 0.066, constipation – 0.212, diarrhoea – 0.287. regarding sociodemographic factors, it was shown that bmi of women ranged from 18.07 to 44.64. The study showed that women with a higher body mass index had more intensive peripheral neuropathy symptoms and side effects from chemotherapy. The time from the diagnosis of the disease to the implementation of the treatment in most cases did not exceed 10 years. a longer time lapse from the diagnosis to the beginning of treatment was associated with more intensive side effects of chemotherapy. Conclusions. The study showed that patients undergoing treatment for ovarian cancer had reduced quality of life in terms of both physical and mental state as compared to healthy women. Sociodemographic factors have an important effect on patients’ quality of life.

family medicine and primary care review

Evaluation of the quality of life of ovarian cancer patients in the context of selected quantitative variables such as body mass, number of miscarriages and time from diagnosis